These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 8591724)

  • 21. Hepatic drug-metabolizing enzymes in primary and secondary tumors of human liver.
    el Mouelhi M; Didolkar MS; Elias EG; Guengerich FP; Kauffman FC
    Cancer Res; 1987 Jan; 47(2):460-6. PubMed ID: 3024821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of breed upon cytochromes P450 and phase II enzyme expression in cattle liver.
    Giantin M; Carletti M; Capolongo F; Pegolo S; Lopparelli RM; Gusson F; Nebbia C; Cantiello M; Martin P; Pineau T; Dacasto M
    Drug Metab Dispos; 2008 May; 36(5):885-93. PubMed ID: 18268077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of intestinal and hepatic P450 enzymes in cynomolgus monkeys with typical substrates and inhibitors for human P450 enzymes.
    Yoda N; Emoto C; Date S; Kondo S; Miyake M; Nakazato S; Umehara K; Kashiyama E
    Xenobiotica; 2012 Aug; 42(8):719-30. PubMed ID: 22324396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of monkey cytochrome P450, P450 CMLd, responsible for S-mephenytoin 4-hydroxylation in hepatic microsomes of cynomolgus monkeys.
    Ohmori S; Chiba K; Nakasa H; Horie T; Kitada M
    Arch Biochem Biophys; 1994 Jun; 311(2):395-401. PubMed ID: 8203903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro studies on the metabolic activation of the furanopyridine L-754,394, a highly potent and selective mechanism-based inhibitor of cytochrome P450 3A4.
    Sahali-Sahly Y; Balani SK; Lin JH; Baillie TA
    Chem Res Toxicol; 1996 Sep; 9(6):1007-12. PubMed ID: 8870989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation.
    Rodrigues AD; Kukulka MJ; Ferrero JL; Cashman JR
    Drug Metab Dispos; 1995 Oct; 23(10):1143-52. PubMed ID: 8654204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical properties of some microsomal xenobiotic-metabolizing enzymes in rabbit small intestine.
    Chhabra RS; Fouts JR
    Drug Metab Dispos; 1976; 4(3):208-14. PubMed ID: 6224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human.
    Edwards RJ; Murray BP; Murray S; Schulz T; Neubert D; Gant TW; Thorgeirsson SS; Boobis AR; Davies DS
    Carcinogenesis; 1994 May; 15(5):829-36. PubMed ID: 8200083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning, expression, and characterization of CYP2D17 from cynomolgus monkey liver.
    Mankowski DC; Laddison KJ; Christopherson PA; Ekins S; Tweedie DJ; Lawton MP
    Arch Biochem Biophys; 1999 Dec; 372(1):189-96. PubMed ID: 10562433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cloning and functional analysis of cytochrome P450 1A2 from Japanese monkey liver: comparison with marmoset cytochrome P450 1A2.
    Narimatsu S; Oda M; Hichiya H; Isobe T; Asaoka K; Hanioka N; Yamano S; Shinoda S; Yamamoto S
    Chem Biol Interact; 2005 Feb; 152(1):1-12. PubMed ID: 15766918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human hepatic cytochrome P450 2D6-like activity in nonhuman primates: catalytic characterization in vitro.
    Wu D; Otton SV; Morrow P; Inaba T; Kalow W; Sellers EM
    J Pharmacol Exp Ther; 1993 Aug; 266(2):715-9. PubMed ID: 8355202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone.
    Uno Y; Fujino H; Kito G; Kamataki T; Nagata R
    Mol Pharmacol; 2006 Aug; 70(2):477-86. PubMed ID: 16648389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Species-specific, P450- and sulfotransferase-mediated novel ring contraction of a naphthyridine-N-oxide compound in cynomolgus monkey.
    Daniels JS; Espina R; Cao K; Yuan H; Lin J; Diamond S; Johnson B; Rodgers J; Prakash S; Unger S; Christ D; Miwa G; Gan LS; Mutlib A
    Chem Res Toxicol; 2007 Nov; 20(11):1709-17. PubMed ID: 17939741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Styrene oxide metabolism in rhesus monkey liver: enzyme activities in subcellular fractions and in isolated hepatocytes.
    Pacifici GM; Lindberg B; Glaumann H; Rane A
    J Pharmacol Exp Ther; 1983 Sep; 226(3):869-75. PubMed ID: 6887015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low glutathione S-transferase dogs.
    Watanabe T; Sugiura T; Manabe S; Takasaki W; Ohashi Y
    Arch Toxicol; 2004 Apr; 78(4):218-25. PubMed ID: 14685647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (+)-bufuralol 1'-hydroxylation activity in human and rhesus monkey intestine and liver.
    Prueksaritanont T; Dwyer LM; Cribb AE
    Biochem Pharmacol; 1995 Oct; 50(9):1521-5. PubMed ID: 7503805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference between species in response to a 3,5-dichloropyridyloxyphenoxy compound: induction of cytochrome P-450 and/or peroxisome proliferation.
    Schmidt U; Machemer L
    Food Addit Contam; 1989; 6 Suppl 1():S41-55. PubMed ID: 2599155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and characterization of two forms of hepatic microsomal cytochrome P450 from untreated cynomolgus monkeys.
    Ohmori S; Horie T; Guengerich FP; Kiuchi M; Kitada M
    Arch Biochem Biophys; 1993 Sep; 305(2):405-13. PubMed ID: 8373178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of isoniazid on hepatic drug oxidation and N-acetylation capacities in rats.
    Desta Z; Siegmund W; Franke G; Beyrich A; Bleyer H
    Pharmazie; 1992 Jun; 47(6):448-51. PubMed ID: 1409842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.